Literature DB >> 19295941

Differential assessment and management of asthma vs chronic obstructive pulmonary disease.

Barbara P Yawn1.   

Abstract

CONTEXT: Asthma and chronic obstructive pulmonary disease (COPD) are prevalent respiratory conditions with overlapping disease characteristics. Differentiation between asthma and COPD is important because several aspects of the guideline-recommended management strategies differ for these conditions. This review identifies the epidemiologic, etiologic, and clinical distinctions of these diseases to assist physicians and other clinicians in differentiating between asthma and COPD. Key components of the guideline-recommended management approaches for these conditions are also reviewed. SEARCH STRATEGIES: Relevant articles were found by searching the MEDLINE database for "asthma" and "chronic obstructive pulmonary disease OR COPD" in association with the terms "diagnostic criteria" and "differential diagnosis". Recent statistical summaries (meta-analyses), reviews, and consensus-type documents were also included. SYNTHESIS: A review of relevant articles found that, although asthma and COPD may occur simultaneously, differences between these diseases are frequently recognized in terms of age at onset, prevalence in relation to age and sex, potential for reversibility of airway obstruction, pathophysiology, and typical symptom presentation. A thorough clinical history in conjunction with lung function testing usually aids in diagnostic distinction and choice of therapeutic interventions. Radiologic imaging and inflammatory marker testing may also aid in the differentiation of these conditions. Over time, disease progression often differs between asthma and COPD.
CONCLUSIONS: Although overlaps exist in the disease characteristics of asthma and COPD, careful history, physical examination, and lung function testing often reveal information that facilitates distinction between these diseases, allowing physicians and other clinicians to better tailor their therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295941      PMCID: PMC2654706     

Source DB:  PubMed          Journal:  Medscape J Med        ISSN: 1934-1997


  68 in total

Review 1.  Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations.

Authors:  Romain A Pauwels
Journal:  Proc Am Thorac Soc       Date:  2004

2.  Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease.

Authors:  R Dahl; L A Greefhorst; D Nowak; V Nonikov; A M Byrne; M H Thomson; D Till; G Della Cioppa
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

Review 3.  Mortality in COPD: Role of comorbidities.

Authors:  D D Sin; N R Anthonisen; J B Soriano; A G Agusti
Journal:  Eur Respir J       Date:  2006-12       Impact factor: 16.671

4.  Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium.

Authors:  W Vincken; J A van Noord; A P M Greefhorst; Th A Bantje; S Kesten; L Korducki; P J G Cornelissen
Journal:  Eur Respir J       Date:  2002-02       Impact factor: 16.671

Review 5.  Asthma and COPD.

Authors:  Tobias Welte; David A Groneberg
Journal:  Exp Toxicol Pathol       Date:  2006-03-31

6.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

Review 7.  Exercise training in chronic obstructive pulmonary disease.

Authors:  Carolyn L Rochester
Journal:  J Rehabil Res Dev       Date:  2003 Sep-Oct

8.  Systemic inflammation and COPD: the Framingham Heart Study.

Authors:  Robert E Walter; Jemma B Wilk; Martin G Larson; Ramachandran S Vasan; John F Keaney; Izabella Lipinska; George T O'Connor; Emelia J Benjamin
Journal:  Chest       Date:  2007-10-01       Impact factor: 9.410

Review 9.  Respiratory failure in chronic obstructive pulmonary disease.

Authors:  P M A Calverley
Journal:  Eur Respir J Suppl       Date:  2003-11

10.  Bronchodilator responsiveness in patients with COPD.

Authors:  D P Tashkin; B Celli; M Decramer; D Liu; D Burkhart; C Cassino; S Kesten
Journal:  Eur Respir J       Date:  2008-02-06       Impact factor: 16.671

View more
  11 in total

Review 1.  Improving the differential diagnosis of chronic obstructive pulmonary disease in primary care.

Authors:  David B Price; Barbara P Yawn; Rupert C M Jones
Journal:  Mayo Clin Proc       Date:  2010-12       Impact factor: 7.616

2.  Pulmonary function tests, sputum induction, and bronchial provocation tests: diagnostic tools in the challenge of distinguishing asthma and COPD phenotypes in clinical practice.

Authors:  Efrossini Dima; Nikoletta Rovina; Christina Gerassimou; Charis Roussos; Christina Gratziou
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

3.  The differentiation of chronic obstructive pulmonary disease from asthma: a review of current diagnostic and treatment recommendations.

Authors:  Pamela Spencer; Bruce Krieger
Journal:  Open Nurs J       Date:  2013-03-22

4.  Diagnosing and treating COPD: understanding the challenges and finding solutions.

Authors:  Len Fromer
Journal:  Int J Gen Med       Date:  2011-10-28

Review 5.  Chronic dry cough: Diagnostic and management approaches.

Authors:  Ashok Mahashur
Journal:  Lung India       Date:  2015 Jan-Feb

6.  Diagnostic accuracy of pre-bronchodilator FEV1/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study.

Authors:  Lisette van den Bemt; Bram C W Wouters; Joke Grootens; Joke Denis; Patrick J Poels; Tjard R Schermer
Journal:  NPJ Prim Care Respir Med       Date:  2014-08-14       Impact factor: 2.871

7.  Cigarette smoke extract promotes proliferation of airway smooth muscle cells through suppressing C/EBP-α expression.

Authors:  Pin Guan; Wentao Cai; Huapeng Yu; Zhiyong Wu; Wei Li; Jie Wu; Juan Chen; Guangqiu Feng
Journal:  Exp Ther Med       Date:  2017-02-15       Impact factor: 2.447

8.  Medical Management of Hospitalized Patients with Asthma or Chronic Obstructive Pulmonary Disease.

Authors:  Theresa N Duong; Amir A Zeki; Samuel Louie
Journal:  Hosp Med Clin       Date:  2017-09-15

9.  Old dilemma: asthma with irreversible airway obstruction or COPD.

Authors:  Fatemeh Fattahi; Judith M Vonk; Nicole Bulkmans; Ruth Fleischeuer; Annette Gouw; Katrien Grünberg; Thais Mauad; Helmut Popper; Aloisio Felipe-Silva; Bart Vrugt; Joanne L Wright; Hui-Min Yang; Janwillem W H Kocks; Machteld N Hylkema; Dirkje S Postma; Wim Timens; Nick H T Ten Hacken
Journal:  Virchows Arch       Date:  2015-09-14       Impact factor: 4.064

10.  Is 'GOLD' standard for the management of COPD in clinical practice?

Authors:  Barbara P Yawn
Journal:  Drugs Context       Date:  2012-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.